[64] silenced AQP5 and investigated the effect on glioma cell migration, this resulted in cell migration inhibition mediated through the suppression of the epidermal growth factor receptor (EGFR)/ERK/p38 mitogen‐activated protein kinase (MAPK) signalling pathway. Here, AQP5 is linked to central nervous system cancer.